Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$911K Buy
3,621
+360
+11% +$77.5K 0.32% 69
2026
Q1
$686K Sell
3,261
-205
-6% -$45.5K 0.29% 82
2025
Q4
$771K Sell
3,466
-24
-0.7% -$5.47K 0.34% 66
2025
Q3
$808K Buy
3,490
+544
+18% +$111K 0.38% 55
2025
Q2
$547K Buy
2,946
+484
+20% +$90K 0.34% 72
2025
Q1
$516K Buy
+2,462
New +$479K 0.39% 66

Other funds holding ABBV

QTR Family Wealth's ABBV Position: Q2 2026 in Review

QTR Family Wealth increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $77.5K and bringing the position to 3,621 shares worth $911K. The position accounts for 0.32% of the portfolio, ranked #69.

QTR Family Wealth first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 2,455 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • QTR Family Wealth held 3,621 shares of AbbVie worth $911K as of Q2 2026.
  • QTR Family Wealth bought 360 AbbVie shares in Q2 2026, an estimated $77.5K.
  • AbbVie made up 0.32% of QTR Family Wealth's portfolio in Q2 2026, its #69 holding.
  • QTR Family Wealth first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 2,455 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on QTR Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.